Read + Share
Amedeo Smart
Independent Medical Education
Yarmolinsky J, Bouras E, Constantinescu A, Burrows K, et al. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis. Diabetologia 2023;66:1481-1500.PMID: 37171501
Email
LinkedIn
Facebook
Twitter
Privacy Policy